echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Another pharmaceutical company stopped the science and technology innovation board

    Another pharmaceutical company stopped the science and technology innovation board

    • Last Update: 2021-06-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, the Shanghai Stock Exchange issued an announcement stating that it would terminate the decision to review the initial public offering of shares of Suzhou Ruibo Biotechnology Co.


    Prior to this, Ruibo Biotech and the sponsor Guotai Junan Securities Co.


    It is worth mentioning that since January this year, in addition to Suzhou Ruibo Biology, Tasly Biology, Eton King Ang, Shanghai Aopu Biology, Beijing Tianguangshi Biology, Dana Biology and other science and technology innovation board IPOs have also been terminated.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.